Edinson Larco-León

Edinson Larco-León

Auto-generated profile, based on publicly available information

Edinson Larco-León

Departamento Académico de Ciencias Universidad Privada Antenor Orrego 13008 Trujillo Peru

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2025 in Revista Mexicana de Ciencias Agrícolas
Verified
Journal Article
Open access
PDF file
CRCynthia Ramos
Cynthia Ramos
PAPercy Asmat
Percy Asmat
PLPedro Lezama-Asencio
Pedro Lezama-Asencio
ELEdinson Larco-León
Edinson Larco-León
PCPablo Chuna-Mogollón
Pablo Chuna-Mogollón
MHManuel MANUEL Hidalgo
Manuel MANUEL Hidalgo
El ‘aguaymanto’ es una especie de gran importancia socioeconómica en diferentes países de América Latina y África. A nivel de fitoquímicos, esta especie presentan una variedad de fitoquímicos de importancia biológica. Por lo cual, este trabajo tiene como objetivo proporcionar un resumen exhaustivo de Physalis peruviana ‘aguaymanto’, enfocándose en sus fitoquímicos y sus aplicaciones en la salud humana. Este trabajo fue realizado en 2024 indica que, a nivel de sus frutos, se encuentran terpenos, compuestos fenólicos, alcoholes, esteroides y withanólidos, destacando a los carotenoides y flavonoides, niveles reducidos de grasa, alto contenido de agua y vitaminas A, B3, B6, C y E, así como de los minerales calcio, potasio, fósforo y magnesio. Esta riqueza en fitoquímicos y nutrientes del aguaymanto se traduce en beneficios significativos para la salud, gracias a sus propiedades antioxidantes, antibacterianas y antiproliferativas. En particular, los cálices y extractos de hojas del aguaymanto han demostrado actividad antihepatotóxica, antifibrótica y antidiabética. En resumen, el aguaymanto presenta un óptimo contenido nutricional y es necesario optimizar la biodisponibilidad de sus componentes para aprovechar plenamente sus beneficios. Debido a su potencial como componente prometedor en alimentos funcionales y fitomedicina, es necesario realizar evaluaciones más profundas sobre su impacto en el bienestar de la humanidad.

31 December 2025 in Annals of Agri-bio Research
Verified
Journal Article
Open access
PDF file
PLPedro Lezama-Asencio
Pedro Lezama-Asencio
ELEdinson Larco-León
Edinson Larco-León
PCPablo Chuna-Mogollón
Pablo Chuna-Mogollón
MLMartha Lezama-Escobedo
Martha Lezama-Escobedo
CRCynthia Ramos
Cynthia Ramos
MHManuel MANUEL Hidalgo
Manuel MANUEL Hidalgo
From Rhizosphere to Crop Production: Evolutionary and Molecular Insights into Plant Growth Promoting Rhizobacteria (PGPR)

20 November 2025 in Journal of Experimental Biology and Agricultural Sciences
Verified
Journal Article
Open access
PDF file
PAPercy Asmat
Percy Asmat
JGJessica Galarreta-Arias
Jessica Galarreta-Arias
CRCynthia Ramos
Cynthia Ramos
EAElio Avila-Vereau
Elio Avila-Vereau
ELEdinson Larco-León
Edinson Larco-León
MHManuel MANUEL Hidalgo
Manuel MANUEL Hidalgo
The objective of this research was to evaluate the relationship between RT-qPCR cycle threshold values (CT) and the severity and mortality of COVID-19 at the "Hospital Regional Docente de Trujillo" in La Libertad, Peru. This analytical observational study was conducted from January to July 2021. Data regarding sex, age group (young adults, adults, older adults), comorbidities, disease severity (mild, moderate, severe), and mortality (deceased or survivor) were extracted from a sample of 260 records. The RT-qPCR test was performed at the Regional Reference Laboratory of La Libertad, and CT values were categorized as low (CT ≤ 25) or high (CT > 25). Data analysis was performed using descriptive statistics and the Pearson chi-square (χ²) test in RStudio. The overall mean age of the patients was 57.5 years, with 62.3% being male and 49.6% presenting comorbidities. Disease severity ranged from mild (1.5%) and moderate (25.8%) to severe (72.6%), resulting in a mortality rate of 39.6%. Low CT values were observed in 75.8% of patients and were significantly associated with both mortality (p = 0.004) and severity (p = 0.002). However, no significant associations were found with sex (p = 0.41), comorbidity (p = 0.61), or age group (p = 0.82). These findings suggest that lower CT values may be associated with an increased risk of severe disease and death, independent of demographic factors or comorbidities. Therefore, CT values could serve as an accessible prognostic marker for early management of COVID-19. Nonetheless, it is important to consider limitations related to sampling timing, assay variability, and the cross-sectional study design.